Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy.

Diabetes Obes MetabJul 8, 2026 (epub)
Clinical ResearchNeurologyOpen access

Dandan Li, Linqi Ouyang, Zhen Chen et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the efficacy and safety of ion channel modulators in treating painful diabetic neuropathy (PDN) across 36 randomized controlled trials involving 6611 participants. The study found that these modulators, particularly calcium channel blockers and sodium channel antagonists, significantly reduced pain and improved quality of life compared to placebo.

Key findings

  • Ion channel modulators significantly reduced pain scores compared to placebo.
  • Calcium channel blockers and sodium channel antagonists improved patient global impression of change (PGIC).
  • 30% and 50% pain reduction was achieved more frequently with ion channel modulators.
  • Adverse events were mild to moderate, with higher discontinuation rates for mirogabalin and oxcarbazepine.

Why it matters

Understanding the efficacy and safety of ion channel modulators can guide clinicians in managing painful diabetic neuropathy, a condition that significantly impacts patients' quality of life. Effective pain management strategies are essential for improving patient outcomes.

Source

Published in Diabetes Obes Metab. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.